EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2020
CVR: 32770487
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -7,043,885 and a net result of DKK -18,365,182 compared with DKK -8,611,095 the year before. Equity in the 2020 report amounted to DKK 64,349,707. The solvency ratio was 78.7%. The company had 16 employees in the financial year.
- Gross Profit
- DKK -7,043,885
- Profit/Loss
- DKK -18,365,182
- Equity
- DKK 64,349,707
- Total Assets
- DKK 81,750,368
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -7M | -18.4M | 64.3M | 16 |
| 2019 | - | 2.8M | -8.6M | -3.7M | 15 |
| 2018 | - | 510K | -9.8M | -14.3M | 15 |
| 2017 | - | 2.5M | -5.1M | -4.6M | 11 |
| 2016 | - | -494K | -7.1M | 551K | 9 |
Official annual report
How creditworthy is EXPRES2ION BIOTECHNOLOGIES ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2019. Gross profit came to DKK 2,813,678, and the net result was DKK -8,611,095.
As of May 26, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2020, EY Partnership P/S has been appointed auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2020, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2020, EY Partnership P/S has stepped down as auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.